StockComparison Logo
vs

NRXS vs GANX

Comparison between Neuraxis Inc (NRXS, Company) and Gain Therapeutics Inc (GANX, Company).

Both NRXS and GANX are from the Healthcare sector.

NRXS vs GANX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
NRXS
$79M
GANX
$78M
Max Drawdown
Winner
NRXS
73.98%
GANX
94.08%
Sharpe Ratio
Winner
NRXS
1.54
GANX
0.64
5Y Beta
Winner
NRXS
1.01
GANX
1.36
Industry
NRXS
Biotechnology
GANX
Biotechnology
P/E Ratio
Winner
NRXS
-9.81
GANX
-3.20
5Y EPS CAGR
NRXS
N/A
GANX
-8.92%
Debt to Equity
Winner
NRXS
1.75%
GANX
2.67%
Free Cash Flow Yield
Winner
NRXS
-7.72%
GANX
-24.78%
P/S Ratio
Winner
NRXS
19.87
GANX
255.50
P/B Ratio
NRXS
15.11
Winner
GANX
5.63

NRXS vs GANX - Historical Returns

Returns include dividend reinvestment.

1M
NRXS
+0.00%
Winner
GANX
+0.57%
3M
NRXS
-13.49%
Winner
GANX
-11.17%
6M
Winner
NRXS
+39.92%
GANX
-14.63%
1Y
Winner
NRXS
+146.38%
GANX
+4.17%
5Y(CAGR)
NRXS
N/A
GANX
-27.92%
Max(CAGR)
Winner
NRXS
+4.32%
GANX
-29.32%

NRXS vs GANX - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearNRXSGANX
2026+52.47%-44.97%
2025+93.19%+38.79%
2024-7.48%-40.41%
2023-55.50%+0.77%
2022N/A-42.46%
2021N/A-51.52%

NRXS vs GANX Drawdown Comparison

The maximum drawdown for NRXS was -73.98%, occurring on Apr 17, 2025. Recovery took 639 trading sessions.

The maximum drawdown for GANX was -94.08%, occurring on Aug 13, 2024. This drawdown has not yet recovered.

The current NRXS drawdown is -22.81%. The current GANX drawdown is -88.92%.

RankNRXSGANX
#1-73.98%
Aug 11, 2023 - Mar 2, 2026
-94.08%
Apr 5, 2021 - Aug 13, 2024
#2-24.29%
May 6, 2026 - Jun 8, 2026
-7.95%
Mar 22, 2021 - Mar 26, 2021
#3-13.25%
Mar 20, 2026 - Apr 24, 2026
N/A
#4-9.37%
Mar 2, 2026 - Mar 10, 2026
N/A
#5-8.49%
Apr 27, 2026 - May 4, 2026
N/A
#6-3.05%
Mar 17, 2026 - Mar 20, 2026
N/A

Correlation

Correlation between NRXS and GANX is -0.09 which considered as a very weak or no correlation - the stocks move independently of each other.

-0.09
-101

Select Stocks to Compare